Lung Cancer News

December 12, 2006

Natco launches Pemnet

Filed under: Uncategorized — admin @ 12:06 am

Natco launches Pemnet
Andhra Cafe, India - Nov 28, 2006 in treating the locally advanced or malignant non-small cell lung cancer.The drug also finds useful in the treatment of malignant pleural mesothelioma in cases

NICE refuses to fund 20,000 cancer drug available in Scotland
This is London, UK - Nov 13, 2006 Apart from Tarceva, there are several other cancer drugs approved in Scotland but denied south of the border, including Alimta for mesothelioma - an asbestos

Asbestos victims want formal inspections
The Age, Australia - Nov 19, 2006 “Experts say that by 2020 there will be 13,000 cases of mesothelioma and up to 40,000 cases of asbestos-related lung cancer,” he said.

Clyde victims of asbestos tell of plight
Glasgow Evening Times, UK - Dec 7, 2006 The Rights of Relatives to Damages (Mesothelioma) Bill would let the immediate families of sufferers claim after they die - irrespective of whether the

Lilly Delivers Promising Update to Wall Street on Strategic
Drug Newswire (press release), CT - Dec 7, 2006 sales. It has become the standard of care worldwide for mesothelioma, with about 75 percent share of market in the major countries.

Smoking can kill you, but there are other causes of lung cancer
Worcester News,  UK - Nov 29, 2006 “For example, at the moment there are two ladies who come to the group who have mesothelioma,” Sue said. “What is shocking is that

What are the causes of lung cancer?
Orlando Sentinel, FL - Dec 3, 2006 In addition to the typical lung cancers, asbestos exposure puts one at risk for an unusual cancer of the lining of the lung, called a mesothelioma.

Sailing into a storm at Holyrood
BBC News, UK - Dec 8, 2006 morning considering a bill which will bring relief to the families of some 500 people - mostly men - who are suffering from the lung cancer, Mesothelioma.

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress